Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN- γ/IL-17 release in bladder cancer treatment
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - March 23, 2022 Category: Cancer & Oncology Authors: Sandra Guallar-Garrido V íctor Campo-Pérez M íriam Pérez-Trujillo Cecilia Cabrera Jordi Senserrich Alejandro S ánchez-Chardi Rosa Maria Rabanal Elisabet G ómez-Mora Estela Noguera-Ortega Marina Luquin Esther Juli án Source Type: research
Correction
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - March 22, 2022 Category: Cancer & Oncology Source Type: research
Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - March 21, 2022 Category: Cancer & Oncology Authors: Donghwan Jeon Douglas G. McNeel Source Type: research
STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - March 21, 2022 Category: Cancer & Oncology Authors: Yanyan Da Yuxia Liu Yuan Hu Wenzeng Liu Junpeng Ma Nan Lu Chengsheng Zhang Cai Zhang Source Type: research
Platinum-based chemotherapy inflames the ovarian carcinoma microenvironment through cellular senescence
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - March 17, 2022 Category: Cancer & Oncology Authors: Beatriz Álvarez-Abril Elena Garc ía-Martínez Lorenzo Galluzzi Source Type: research
